.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Fortis Healthcare recently released its Fortis Healthcare Q3 results, showing a 22% year-on-year decline in consolidated profit. Although the profit after tax (PAT) reached Rs 197 crore, this figure dropped from Rs 254 crore in the year-ago period. Consequently, the financial landscape reflects both significant operational hurdles and strong underlying revenue growth across its hospital network.
The reported profit includes a net exceptional loss of Rs 45.9 crore. Primarily, this loss stems from a one-time impact related to new labour codes. Moreover, the company balanced this against a reversal of impairment in an associate firm of Rs 9.4 crore. Meanwhile, revenue performed exceptionally well, increasing to Rs 2,265 crore compared to Rs 1,928 crore in the prior fiscal year. Therefore, the core business remains robust despite the temporary bottom-line pressure caused by regulatory adjustments.
Fortis Healthcare MD and CEO, Ashutosh Raghuvanshi, highlighted healthy growth in key specialties during the quarter. Specifically, renal sciences and orthopedics grew by 27% and 20%, respectively, over the previous period. Furthermore, the company is actively expanding its footprint in Bengaluru through recent acquisitions. This move strengthens its presence from 900 beds to a potential capacity of over 1,500 beds. Additionally, management is evaluating further inorganic opportunities within existing clusters to sustain clinical momentum.
Q1: What caused the decline in Fortis Healthcare\'s Q3 net profit?
The profit decline was primarily due to an exceptional loss of Rs 45.9 crore, which was linked to the one-time impact of new labour codes.
Q2: How did the revenue perform during the December 2025 quarter?
Revenue increased significantly to Rs 2,265 crore, representing a healthy rise from Rs 1,928 crore in the same quarter of the previous year.
Q3: Which medical specialties saw the most growth in this period?
Renal sciences and orthopedics were the top-performing specialties, growing by 27% and 20% respectively, indicating high demand for these clinical services.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Fortis Healthcare reported a 22% dip in Q3 profit to Rs 197 crore, impacted by one-time labour code costs, despite a strong 17.5% rise in consolidated reven...
5 months ago
Discover clinical pitfalls in diagnosing SGLT2 inhibitor ketoacidosis in the ICU. Learn how cardiac surgery and GLP-1 agonist interactions trigger euglycemic DKA and explore management strategies.
Today
A new study reveals that pregnant women with gestational diabetes show altered neural responses to high-fat visual food cues compared to healthy controls. Using visual evoked potentials, researchers found that these early neurophysiological responses correlate with HbA1c levels and metabolic health.
Today
A multi-state Indian study by KMCRI reveals alarming cardiovascular risk markers among healthy adolescents and young adults, including hyperhomocysteinemia and early blood vessel damage.
Today
A 69-year-old male presented with a painless thigh mass, initially suspected as a primary soft tissue tumor. Post-surgical pathology confirmed squamous cell carcinoma. Subsequent FDG PET/CT and EBUS biopsy identified primary lung cancer, proving skeletal muscle metastasis can be the first sign of occult malignancy.
Today
Per-protocol analysis of the PRAGUE-25 trial demonstrates that catheter ablation significantly reduces atrial fibrillation burden, hospitalizations, and emergency visits compared to lifestyle modification plus antiarrhythmic drugs in obese patients.
Today
